Human NKp44/NCR2 Antibody, R&D Systems™

NKp44/NCR2

Monoclonal

LYOPH

Western Blot 2 ug/mL

O95944

NCR2

Mouse myeloma cell line NS0-derived recombinant human NKp44/NCR2 Gln22-Pro190 Accession # O95944

100 μg

Primary

Detects human NKp44/NCR2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant mouse MAR-1, recombinant human (rh) NKp30, rhNKp46, or rhNKp80 is observed.

Human

Purified

Western Blot

253422

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

CD336, CD336 antigen, LY95, LY95lymphocyte antigen 95 homolog (activating NK-receptor; NK-p44), lymphocyte antigen 95 (activating NK-receptor; NK-p44), Lymphocyte antigen 95 homolog, natural cytotoxicity triggering receptor 2, Natural killer cell p44-related protein, NCR2, NK cell activating receptor (NKp44), NK cell-activating receptor, NKP44, NK-p44dJ149M18.1

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

9436

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2b